|Bid||39.22 x 1000|
|Ask||39.25 x 800|
|Day's Range||39.14 - 39.75|
|52 Week Range||31.31 - 47.22|
|Beta (3Y Monthly)||0.22|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 19, 2019 - Aug 23, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||43.72|
Premier Inc., a leading healthcare improvement company, has partnered with 26-year, industry expert John Gorman to support its portfolio of value-based payment services for Medicare Advantage providers and participants. Premier members are demanding more support as they build successful Medicare Advantage strategies. Gorman will work directly with Premier’s strategic advisory team to assist providers with Medicare Advantage strategies for success in their markets.
Premier Inc NASDAQ/NGS:PINCView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for PINC with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $4.25 billion over the last one-month into ETFs that hold PINC are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Boston Children’s Hospital, one of the largest pediatric medical centers in the U.S., has partnered with Premier Inc. (PINC), a leading healthcare improvement company, to foster optimal management of its supply chain portfolio. Ranked the #1 children's hospital in the nation by U.S. News & World Report, Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School.
Susan DeVore became the CEO of Premier, Inc. (NASDAQ:PINC) in 2013. This report will, first, examine the CEO...
Premier Inc. (PINC), a healthcare improvement company, is working with 10 leading hospitals on a perinatal collaborative designed to reach zero preventable maternal and neonatal harm and deaths. Over the next two years, hospitals in Premier’s Perinatal Collaborative will design, test and adopt evidenced-based improvement strategies that can be replicated, standardized and scaled nationally. The collaborative, which launched in June, is part of Premier’s Bundle of Joy™ Campaign to transform the quality, safety and cost of maternal and infant health.
Cysteine hydrochloride has been in shortage in the U.S. since 2015. This FDA-approved New Drug Application (NDA) for cysteine hydrochloride injection is held by Exela Pharma Sciences, LLC, a U.S.-based manufacturer. Current supplies of cysteine hydrochloride injection are imported from Canada under special FDA rules that allow shortage drugs to be sourced abroad if no domestic supplies are available.
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 40% and 25% respectively. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted […]
Premier Inc. , a leading healthcare improvement company, has recognized dozens of hospitals, health systems and suppliers for their outstanding work to improve healthcare quality and costs.
Premier Inc. (PINC), a healthcare improvement company, and Pensiamo Inc., a cognitive supply chain company, have partnered to launch a new pharmaceutical supply chain solution that was co-developed with UPMC, a world-renowned healthcare provider and insurer. CognitiveRx™ is a comprehensive pharmaceutical supply chain solution that predicts, manages and solves for challenges related to drug shortages, inflation, declining reimbursement and other factors impacting the life sciences supply chain. UPMC, which owns Pensiamo, will be the first to implement CognitiveRx to more precisely monitor market demand signals, predict shortage risk and recommend inventory levels that support its ability to insulate patient care from supply disruption.
ProvideGx, LLC, a consolidated subsidiary of Premier Inc. (PINC) and a healthcare improvement company developing a more stable and reliable supply chain for generic drugs in short supply, is collaborating with Fresenius Kabi to help mitigate national shortages of injectable thiamine, lidocaine, diphenhydramine, hydromorphone and morphine sulfate. Fresenius Kabi, a 2018 recipient of the Food and Drug Administration’s (FDA’s) Drug Shortage Assistance Award, is a global healthcare company that is a leading developer, manufacturer and supplier of injectable medicines used in hospitals and clinics to treat patients with critical and chronic conditions.
Premier Inc. (PINC), a leading healthcare improvement company, is exiting its specialty pharmacy business to enhance the company’s focus on the continuing evolution of its core supply chain, enterprise analytics and performance improvement capabilities. On May 6, 2019, certain of Premier’s consolidated subsidiaries entered into a definitive asset purchase and sale agreement with ProCare Pharmacy, L.L.C., a subsidiary of CVS Health Corporation, under which Premier will sell certain assets related to its specialty pharmacy business for $22.5 million, plus up to an additional $20.0 million for inventory, each subject to adjustment. The transaction is expected to close in the current quarter ending June 30, 2019.
Premier Inc. (PINC), a leading healthcare improvement company, has expanded its partnership with Ballad Health, an integrated health system that serves 29 counties across four Southeastern states. Ballad Health will implement Premier’s performance improvement infrastructure and leverage strategic supply chain services to drive high-value care across its enterprise.
Premier Inc. (PINC), a leading healthcare improvement company, named Michael J. Alkire its new President and Craig S. McKasson its new Chief Administrative Officer. Alkire has served as Chief Operating Officer of Premier since 2013. In addition to serving as Chief Administrative Officer, McKasson will retain his role as Senior Vice President, Chief Financial Officer and Treasurer of Premier, as he has since 2013.
Premier Inc. (PINC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
It hasn't been the best quarter for Premier, Inc. (NASDAQ:PINC) shareholders, since the share price has fallen 18% in that time. On the bright side the share price is up over the last half decade. In that time, it...
Premier Inc. (PINC) plans to report fiscal 2019 third-quarter financial results the morning of May 7, 2019, followed by a conference call at 8 a.m. ET to discuss the results. During the conference call, Premier’s management team will review the company’s performance for the three months ended March 31, 2019 and discuss management’s outlook for the remainder of fiscal 2019. The conference call will be webcast live and can be accessed through a link provided on the investor relations page of Premier's website at investors.premierinc.com.